Researchers evaluated an electronic health record-based intervention that identified patients with metastatic cancer for a multipronged approach to their in-hospital care.

Radiotherapy is a cornerstone of prostate cancer treatment. Moderately hypofractionated radiotherapy (MHFRT) is advancing this care by delivering higher radiation doses per fraction over fewer ...

Surufatinib did not provide an overall survival (OS) benefit over placebo in patients with advanced neuroendocrine tumors (NETs) enrolled in a pair of phase 3 trials. However, there was a high ...

The cohorts had similar proportions of females (39% and 40%), non-White (6% vs 4%) and Hispanic (4% vs 1%) patients, those with newly-diagnosed disease (42% for both), and months post MM diagnosis ...

Researchers studied the progression-free and overall survival rates of patients with advanced melanoma after cessation of immune checkpoint inhibitor therapy.

Psychological and informational needs are the most common unmet needs among adult survivors of thyroid cancer, according to findings from a systematic review published in JAMA Otolaryngology-Head & ...

Among the included patients, 1359 (43.8%) had uncontrolled pain, and 1044 (33.6%) experienced high-impact pain. Patients with uncontrolled pain were nearly 10 times more likely to develop OUD ...

CAR T-cell therapy showed encouraging efficacy and good safety in newly diagnosed Ph-positive ALL,” the researchers wrote.

A prognostic index can be used to identify patients with estrogen receptor (ER)-positive, HER2-negative early breast cancer who can safely forgo adjuvant chemotherapy as well as patients who require ...

Patients with prostate cancer may have a lower risk of recurrence if they take multivitamin supplements after diagnosis, new data suggest.

Findings seen in women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for HR-positive breast cancer.

Researchers studied the relationship between lymphovascular invasion and adverse outcomes in patients with cutaneous squamous cell carcinoma.